Ecolab Inc. (ECL) said that it has entered into an agreement with AvidBiotics Corp. under which they will jointly work to develop a new technology that could significantly reduce the presence of the pathogen E. coli O157:H7 in red meat products.
The companies' intent is to successfully commercialize AvidBiotics' proprietary protein-based antibacterial technology, which can be targeted against specific bacterial pathogens. While this platform technology may be applicable to numerous food pathogens, the companies are first targeting the food pathogen E. coli in red meat.
For comments and feedback: editorial@rttnews.com